MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$154,165
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Services
0
0
0
0*
Cost of services
0
0
-
-
Gross profit
0
0
-
-
Research and development expense
-
0
-
0*
General and administrative expenses
162,763
72,963
64,002
162,286.25*
Total operating expenses
162,763
72,963
64,002
162,286.25*
Loss from operations
-162,763
-72,963
-64,002
-162,286.25*
Capital loss
-
0
-
0*
Financial loss, net
-
-
-
10,571.25*
Financial income (loss), net
8,598
28,865
-49,717
-
Net (loss)
-154,165
-44,098
-113,719
-172,857.5
Profit (loss) from available for sale assets
-
0
0
-
Total comprehensive income (loss)
-154,165
-44,098
-113,719
-172,857.5
Basic EPS
0
0
0
-0.001
Diluted EPS
0
0
0
-0.001
Basic Average Shares
1,318,594,182
931,015,714
732,857,211
198,239,676
Diluted Average Shares
1,318,594,182
931,015,714
732,857,211
198,239,676
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
income (loss)
-$154,165
(-158.12%↓ Y/Y)
Net (loss)
-$154,165
(-158.12%↓ Y/Y)
Financial income (loss),
net
$8,598
(144.44%↑ Y/Y)
Loss from operations
-$162,763
(-303.08%↓ Y/Y)
Total operating
expenses
$162,763
(303.08%↑ Y/Y)
General and
administrative expenses
$162,763
(303.08%↑ Y/Y)
Buy us a coffee
CNBX Pharmaceuticals Inc. (CNBX)
CNBX Pharmaceuticals Inc. (CNBX)